Q&A with Avacta's CEO Alastair Smith
Episode 1743, Dec 13, 2023, 01:00 PM
Following the release of important safety & efficacy data wrt Avacta's AVA6000 phase 1a clinical trial, I was delighted to catchup again with CEO Alastair Smith, who took me through the hugely significant news.